Naphthylaminopropane

Naphthylaminopropane
Clinical data
Other names	NAP; Naphthylisopropylamine; NIPA; PAL-287; Naphetamine; Amnetamine; 1-(2-Naphthyl)-2-aminopropane; beta-Methylnapthylethylamine; β-Methylnaphthylethylamine; 1-(β-Naphthyl)-2-aminopropane
Routes of; administration	Oral
ATC code	None;
Legal status
Legal status	In general: uncontrolled;
Identifiers
	IUPAC name 1-(Naphthalen-2-yl)propan-2-amine;
CAS Number	18085-03-5 ;
PubChem CID	10219723;
ChemSpider	8395215;
UNII	53PF675WUK;
ChEMBL	ChEMBL471839;
CompTox Dashboard (EPA)	DTXSID70630474 ;
Chemical and physical data
Formula	C13H15N
Molar mass	185.270 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(N)Cc2ccc1ccccc1c2;
	InChI InChI=1S/C13H15N/c1-10(14)8-11-6-7-12-4-2-3-5-13(12)9-11/h2-7,9-10H,8,14H2,1H3; Key:UPQSZFKXKRKCGZ-UHFFFAOYSA-N;

Naphthylaminopropane (NAP; code name PAL-287), also known as naphthylisopropylamine (NIPA), is an experimental drug of the amphetamine and naphthylaminopropane families that was under investigation for the treatment of alcohol and stimulant addiction.